Ventricular Irruption Using 5-Aminolevulinic Acid in Patients with Glioblastoma

Special Article - Brain Tumor

Austin J Radiol. 2019; 6(3): 1101.

Ventricular Irruption Using 5-Aminolevulinic Acid in Patients with Glioblastoma

Salvador Manrique-Guzman* and Alejandro González-Garay

¹Department of Neurosurgery, Hospital San Ángel Inn Patriotismo, Mexico City, Mexico

²Methodology Research Unit, Instituto Nacional de Pediatría, Mexico City, Mexico

*Corresponding author: Salvador Manrique-Guzman, Hospital San Ángel Inn Patriotismo, Avenida Patriotismo 67. Office 721. Col. San Juan, Mexico City, Mexico

Received: October 09, 2019; Accepted: October 21, 2019; Published: October 28, 2019

Abstract

Glioblastoma is one of the most malignant brain tumors with a mean survival time in adults of 12-16 months after diagnosis. New evidence points toward always achieving maximal safe surgical resection. Tumor located near to the lateral ventricles can have increased risk of ventricular breach. Ventricular irruption during surgery increase the possibility of acquiring hydrocephalus. We prospectively reviewed 168 patients with newly diagnosed and previously untreated GBM diagnosed between 2005 and 2013 at a single center. Ventricular irruption was register if stated in the surgical technique note or when evident in the postoperative scan. A total of 48 patients were recruited, 5-ALA guided surgery was employed in 30 cases of total resection, 17 for subtotal resection and 1 biopsy. There was not increased risk of ventricular irruption during 5-ALA surgery. Data presented in this study suggest that 5-ALA guided surgery does not increases the risk of ventricular irruption and neither the development of late-onset communicating hydrocephalus.

Keywords: High-grade glioma; Aminolevulinic acid; Lateral ventricles; 5-ALA surgery

Introduction

Glioblastoma is one of the most malignant brain tumors with a mean survival time in adults of 12-16 months after diagnosis. New evidence points toward always achieving maximal surgical resection. Surgery provides some survival benefit (›78% resection), rapid reduction of tumor bulk mass effect with concomitant symptoms palliation and provides tissue for histopathological diagnosis [1-3]. Despite major advances in microsurgical techniques and technological nuances, the median survival still less than 15 months [4,5]. Tumor located near to the lateral ventricles can have increased risk of ventricular breach.

Ventricular irruption during surgery increase the possibility of acquiring hydrocephalus, estimated to occur in 15% of surgical cases with a 4% incidence [6-8]. A ventricular entry during resection may be associated with CFS dissemination of the tumor cells, and CFS dissemination leads to CFS malabsorption followed by postoperative communicating hydrocephalus [9].

The 5-Aminolevulinic Acid (5-ALA) fluorescence guided resection for high-grade glioma has become a useful took to achieve maximal safe tumor removal decreasing the probability of local recurrence [10]. The range of tumor resection can be enhanced under fluorescence guidance with Protoporfirin IX (PpIX) synthesized by 5-ALA. With the intention of achieving a gross total resection for the treatment of glioblastoma, the incidence of ventricular entry during resection may increase, especially tumors located near the lateral ventricles are more prone to by breached during tumor resection [9]. The aim of this paper is to establish the relationship between ventricular irruption and use of 5-ALA fluorescence guided surgery in high-grade tumors.

Methods

We prospectively reviewed 168 patients with newly diagnosed and previously untreated GBM diagnosed between 2005 and 2013 at a single center in University of Tübingen Hospital, Germany, who had ventricular irruption during tumor resection using 5-ALA [11,12]. We included all adult patients had high-grade glioma cytoreductive surgery using 5-ALA for fluorescence guided resection, the exclusion criteria like surgery rejection, known 5-ALA allergy, coagulopathy, absence of postoperative imaging (‹72 hrs) and porphyria, but no cases were register Perioperatively, all patients received 5-ALA 3 hours prior to surgery in a dose of 20 mg per kilogram body weight. Intraopratively, fluorescence was visualized using an adapted microscope (Pentero, Carl Zeiss Meditec, Oberkochen, Germany). Biopsy samples were included. Radiotherapy and concurrent Temozolamide (TMZ) were given according to standard guidelines (75mg/m2 per day) [4]. Ventricular irruption was register if stated in the surgical technique note or when evident in the postoperative scan Figure 1. Epidemiological data (age, gender), data regarding tumor localization and further progression were collected if available. We divided the 5-ALA patient according to the risk of ventricular irruption in relationship to it’s location near the lateral ventricles. Since this was a retrospective review using patients electronic chart, no patient consent or ethical committee was obtained.